CIBC Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

CIBC Asset Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,402	Closed	-$397K	–	1514
2021 Q2	$397K	Hold	2,402	–	–	﹤0.01%	879
2021 Q1	$368K	Sell	2,402 -124	-5%	-$16.8K	﹤0.01%	879
2020 Q4	$317K	Hold	2,526	–	–	﹤0.01%	878
2020 Q3	$256K	Buy	2,526 +63	+3%	+$6.42K	﹤0.01%	895
2020 Q2	$240K	Hold	2,463	–	–	﹤0.01%	886
2020 Q1	$205K	Hold	2,463	–	–	﹤0.01%	870
2019 Q4	$274K	Buy	2,463 +158	+7%	+$16.3K	﹤0.01%	913
2019 Q3	$229K	Hold	2,305	–	–	﹤0.01%	963
2019 Q2	$229K	Hold	2,305	–	–	﹤0.01%	981
2019 Q1	$254K	Hold	2,305	–	–	﹤0.01%	914
2018 Q4	$212K	Hold	2,305	–	–	﹤0.01%	928
2018 Q3	$254K	Hold	2,305	–	–	﹤0.01%	925
2018 Q2	$215K	Buy	+2,305	New	+$198K	﹤0.01%	998

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

CIBC Asset Management's PRAH Position: Q3 2021 in Review

CIBC Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,402 shares — an estimated $397K sold.

CIBC Asset Management first reported a position in PRAH in Q2 2018 and held it in 13 quarters. The position peaked at $397K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

CIBC Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
CIBC Asset Management sold 2,402 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $397K.
CIBC Asset Management first reported a position in PRA Health Sciences, Inc. in Q2 2018 and held it in 13 quarters.
CIBC Asset Management's PRA Health Sciences, Inc. position peaked at $397K in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on CIBC Asset Management's 13F filing for Q3 2021, filed 9 Nov 2021.